Nov 10, 2021 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the discussion on the company's Q2 H1 FY '22 financial results of Alembic Pharmaceuticals Limited.
Joining us on this call today are Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. RK Baheti, Director Finance and CFO; Mr. Mitanshu Shah, Head Finance; and Mr. Ajay Kumar Desai, Senior VP Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. RK Baheti, Director Finance and CFO. Thank you, and over to you, Mr. Baheti.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you. Good evening, everyone. Thank you all for joining the second quarter results conference call. I'm sure you would have received the results by now. However, let me briefly take you through the highlights for the quarter/half year ended 30th of September 2021 financial.
All of you are aware that H1 of last year, particularly Q2 of last year was exceptionally good
Q2 2022 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Nov 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers